STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB)
CUSIP: 34385P108
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 384,731,503
- Total 13F shares
- 302,674,845
- Share change
- +16,914,793
- Total reported value
- $387,376,385
- Put/Call ratio
- 67%
- Price per share
- $1.28
- Number of holders
- 159
- Value change
- +$21,629,884
- Number of buys
- 64
- Number of sells
- 66
Quarterly Holders Quick Answers
What is CUSIP 34385P108?
CUSIP 34385P108 identifies LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 34385P108:
Top shareholders of LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Casdin Partners Master Fund, L.P. |
3/4/5
|
Director, 10%+ Owner |
19%
|
75,001,062
|
$107,795,554 | +$16,303,018 | 02 Dec 2025 | |
| Casdin Capital, LLC |
13D/G
13F
|
Eli Casdin · Company |
24%
|
93,442,787
|
$107,459,205 | +$14,465,243 | 25 Nov 2025 | |
| VIKING GLOBAL INVESTORS LP |
13F
3/4/5
|
Company · 10%+ Owner |
15%
|
58,651,170
|
$76,246,521 | — | 30 Sep 2025 | |
| Caligan Partners LP |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
16,265,374
mixed-class rows
|
$34,539,714 | — | 29 Jun 2023 | |
| BlackRock, Inc. |
13F
|
Company |
6.5%
|
24,920,918
|
$32,397,194 | — | 30 Sep 2025 | |
| MAK Capital Fund LP |
13D/G
|
— |
5.2%
|
19,967,565
|
$25,564,473 | $0 | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.5%
|
17,245,583
|
$22,419,257 | — | 30 Sep 2025 | |
| MAK CAPITAL ONE LLC |
13F
|
Company |
4.1%
|
15,931,806
|
$20,711,348 | — | 30 Sep 2025 | |
| Long Focus Capital Management, LLC |
13F
|
Company |
3%
|
11,362,804
|
$14,771,645 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
7,468,917
|
$9,711,117 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.7%
|
6,402,649
|
$8,323,444 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.7%
|
6,355,152
|
$8,261,698 | — | 30 Sep 2025 | |
| Hollow Brook Wealth Management LLC |
13F
|
Company |
1.5%
|
5,775,739
|
$7,508,461 | — | 30 Sep 2025 | |
| Amova Asset Management Americas, Inc. |
13F
|
Company |
1.4%
|
5,391,829
|
$7,009,378 | — | 30 Sep 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
1.4%
|
5,391,829
|
$7,009,378 | — | 30 Sep 2025 | |
| Neuberger Berman Group LLC |
13F
|
Company |
1.2%
|
4,725,812
|
$6,136,032 | — | 30 Sep 2025 | |
| Tikvah Management LLC |
13F
|
Company |
0.92%
|
3,551,152
|
$4,616,498 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.83%
|
3,174,634
|
$4,127,025 | — | 30 Sep 2025 | |
| ARK Investment Management LLC |
13F
|
Company |
0.79%
|
3,021,728
|
$3,928,246 | — | 30 Sep 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.73%
|
2,804,719
|
$3,646,135 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.67%
|
2,593,910
|
$3,372,083 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.65%
|
2,504,180
|
$3,255,434 | — | 30 Sep 2025 | |
| Jeffrey G. Black |
3/4/5
|
SVP & Chief Financial Officer |
—
mixed-class rows
|
966,346
mixed-class rows
|
$2,532,070 | — | 20 Aug 2024 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.49%
|
1,883,179
|
$2,448,133 | — | 30 Sep 2025 | |
| Slate Path Capital LP |
13F
|
Company |
0.42%
|
1,615,000
|
$2,099,500 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.38%
|
1,453,575
|
$1,889,647 | — | 30 Sep 2025 | |
| Pacific Capital Partners Ltd |
13F
|
Company |
0.34%
|
1,325,000
|
$1,722,500 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.34%
|
1,295,966
|
$1,684,756 | — | 30 Sep 2025 | |
| Casdin Amplify Fund, LP |
3/4/5
|
Director |
—
class O/S missing
|
545,000
|
$1,117,250 | — | 18 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.21%
|
798,138
|
$1,037,580 | — | 30 Sep 2025 | |
| Stephen Christopher Linthwaite |
3/4/5
|
President & CEO |
—
mixed-class rows
|
390,252
mixed-class rows
|
$1,004,213 | — | 22 Feb 2022 | |
| JBF Capital, Inc. |
13F
|
Company |
0.2%
|
770,654
|
$1,001,850 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.17%
|
657,212
|
$854,375 | — | 30 Sep 2025 | |
| Vikram Jog |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
297,859
mixed-class rows
|
$762,479 | — | 21 Feb 2023 | |
| Jeremy Steven Davis |
3/4/5
|
SVP Chief Commercial Officer |
—
mixed-class rows
|
243,824
mixed-class rows
|
$667,438 | — | 21 Feb 2023 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.13%
|
512,708
|
$666,521 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.13%
|
488,443
|
$634,976 | — | 30 Sep 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.13%
|
488,099
|
$634,529 | — | 30 Sep 2025 | |
| Swiss National Bank |
13F
|
Company |
0.12%
|
470,660
|
$611,858 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.12%
|
455,814
|
$592,558 | — | 30 Sep 2025 | |
| NEEDHAM INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.11%
|
434,435
|
$564,766 | — | 30 Sep 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.11%
|
420,614
|
$546,793 | — | 30 Sep 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.11%
|
407,755
|
$530,082 | — | 30 Sep 2025 | |
| Intellectus Partners, LLC |
13F
|
Company |
0.11%
|
404,702
|
$526,113 | — | 30 Sep 2025 | |
| Fenel M. Eloi |
3/4/5
|
Director |
—
mixed-class rows
|
361,843
mixed-class rows
|
$520,430 | — | 20 Jun 2025 | |
| Nicolas Barthelemy |
3/4/5
|
Director |
—
class O/S missing
|
204,077
|
$518,356 | — | 01 Apr 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.1%
|
393,019
|
$510,925 | — | 30 Sep 2025 | |
| Frank Witney |
3/4/5
|
Director |
—
mixed-class rows
|
340,747
mixed-class rows
|
$498,068 | — | 20 Jun 2025 | |
| Carlos Paya V |
3/4/5
|
Director |
—
mixed-class rows
|
162,224
mixed-class rows
|
$454,505 | — | 14 Jun 2023 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.09%
|
331,224
|
$430,591 | — | 30 Sep 2025 |
Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q4 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.